Canaccord Raises C3.ai Price Target as Siebel Becomes CEO
Canaccord Genuity raised its price target on C3.ai to $8 from $7 after Tom Siebel returned as CEO, amid preliminary Q...
See what results to expect from zero based budgeting and how to monitor progress with clear, actionable metrics.
19,375 articlesCanaccord Genuity raised its price target on C3.ai to $8 from $7 after Tom Siebel returned as CEO, amid preliminary Q...
A notable fund sold millions of dollars’ worth of shares as this obesity drug stock jumped on Phase 3 momentum. Here’...
A bold $1.5 billion investment signals Boston Scientific’s shift into transcatheter aortic valve replacement. Explore...
Netflix kept growing its revenue and user base, yet the stock stumbled. This article unpacks why the netflix stock fa...
When Insperity s top executive buys a sizable stake, investors sit up. This article breaks down what insperity stock ...
Lam Research surged about 21% from its June trough as markets priced in a slower path for rate hikes. This report wei...
The ADA conference spotlighted Lilly and Novo Nordisk in the GLP-1 race. This deep dive explains what the claims mean...
In volatile markets, pulling back can create buying opportunities. This article highlights three growth stocks to buy...
Palantir rallies on stronger AI demand and improving margins, positioning it as a core pick in this best stocks 2026 ...
Chipotle stock topped market today as investors cheered a mix of global expansion news, digital growth, and improving...
As Bloom Energy charts a post-2026 path, investors wonder if hydrogen fuel cells can sustain durable growth. This art...
Bloom Energy has surged 497% over the past year, shaking up portfolios and headlines. This guide breaks down what the...